Expression of the IL-18-related gene PTX3 correlates with clinicopathological features and prognosis in glioma patients

Background Glioma, a highly aggressive brain tumor, presents significant challenges in prognosis and treatment. This study investigates the role of PTX3 expression in glioma and its correlation with patient outcomes, addressing a gap in current research regarding its molecular mechanisms. Materials...

Full description

Saved in:
Bibliographic Details
Main Authors: Delin Wang, Cuimei Liu, Bohao Sun, Xiaodong Zhang, Yejun Zhou, Zhonglin Hu, Duanzheng Cao, Jing Zhang, Jinfang Xu
Format: Article
Language:English
Published: PeerJ Inc. 2025-07-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/19675.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849320798860345344
author Delin Wang
Cuimei Liu
Bohao Sun
Xiaodong Zhang
Yejun Zhou
Zhonglin Hu
Duanzheng Cao
Jing Zhang
Jinfang Xu
author_facet Delin Wang
Cuimei Liu
Bohao Sun
Xiaodong Zhang
Yejun Zhou
Zhonglin Hu
Duanzheng Cao
Jing Zhang
Jinfang Xu
author_sort Delin Wang
collection DOAJ
description Background Glioma, a highly aggressive brain tumor, presents significant challenges in prognosis and treatment. This study investigates the role of PTX3 expression in glioma and its correlation with patient outcomes, addressing a gap in current research regarding its molecular mechanisms. Materials and Methods RNA sequencing data and clinical information for glioma patients were obtained from The Cancer Genome Atlas (TCGA). A multigene prognostic signature based on IL-18 signaling-related genes (ISRGs) was constructed using the least absolute shrinkage and selection operator (LASSO) Cox regression method. The functional roles of PTX3 were analyzed through Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA). Single-sample GSEA (ssGSEA) was used to assess the association between PTX3 expression and immune cell infiltration. The relationship between PTX3 expression and clinicopathological features was also examined. Prognostic relevance was evaluated using univariate and multivariate Cox regression models, and Kaplan–Meier survival analysis was performed. PTX3 protein expression was validated via immunohistochemistry in 56 glioma specimens. Results The LASSO Cox regression model identified a nine-gene prognostic signature, including BMP2, NCF1, HSPB1, PIGT, PTX3, CCNA2, CCNB2, CCN4, and DES. Functional enrichment analysis revealed that PTX3-associated differentially expressed genes were significantly enriched in pathways such as cytokine–cytokine receptor interaction and PI3K-Akt signaling, which are critical for immune response and cell proliferation in glioma. PTX3 expression showed a strong correlation with immune cell infiltration, particularly macrophages, neutrophils, T cells, and natural killer cells, suggesting a role in modulating the tumor microenvironment. Pan-cancer analysis indicated that PTX3 is markedly upregulated in various cancers, especially gliomas, highlighting its potential as a biomarker. PTX3 expression was also associated with clinical features such as WHO grade, IDH mutation status, and 1p/19q co-deletion, with higher PTX3 levels linked to poorer survival outcomes. Immunohistochemistry confirmed elevated PTX3 protein expression in both lower-grade glioma and glioblastoma multiforme. Conclusions These findings highlight the critical role of PTX3 in glioma and suggest its potential as both a prognostic biomarker and therapeutic target. This study provides a foundation for future research into targeted therapies involving PTX3.
format Article
id doaj-art-407fcd018f2f4f60bab2b99ea8197594
institution Kabale University
issn 2167-8359
language English
publishDate 2025-07-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj-art-407fcd018f2f4f60bab2b99ea81975942025-08-20T03:49:56ZengPeerJ Inc.PeerJ2167-83592025-07-0113e1967510.7717/peerj.19675Expression of the IL-18-related gene PTX3 correlates with clinicopathological features and prognosis in glioma patientsDelin Wang0Cuimei Liu1Bohao Sun2Xiaodong Zhang3Yejun Zhou4Zhonglin Hu5Duanzheng Cao6Jing Zhang7Jinfang Xu8Department of Neurosurgery, Jiande First People’s Hospital, Hangzhou, Zhejiang, ChinaDepartment of Neurology, Jiande First People’s Hospital, Hangzhou, Zhejiang, ChinaDepartment of Pathology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaDepartment of Neurosurgery, Jiande First People’s Hospital, Hangzhou, Zhejiang, ChinaDepartment of Neurosurgery, Jiande First People’s Hospital, Hangzhou, Zhejiang, ChinaDepartment of Neurosurgery, Jiande First People’s Hospital, Hangzhou, Zhejiang, ChinaDepartment of Neurosurgery, Jiande First People’s Hospital, Hangzhou, Zhejiang, ChinaDepartment of Pathology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaDepartment of Neurosurgery, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaBackground Glioma, a highly aggressive brain tumor, presents significant challenges in prognosis and treatment. This study investigates the role of PTX3 expression in glioma and its correlation with patient outcomes, addressing a gap in current research regarding its molecular mechanisms. Materials and Methods RNA sequencing data and clinical information for glioma patients were obtained from The Cancer Genome Atlas (TCGA). A multigene prognostic signature based on IL-18 signaling-related genes (ISRGs) was constructed using the least absolute shrinkage and selection operator (LASSO) Cox regression method. The functional roles of PTX3 were analyzed through Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA). Single-sample GSEA (ssGSEA) was used to assess the association between PTX3 expression and immune cell infiltration. The relationship between PTX3 expression and clinicopathological features was also examined. Prognostic relevance was evaluated using univariate and multivariate Cox regression models, and Kaplan–Meier survival analysis was performed. PTX3 protein expression was validated via immunohistochemistry in 56 glioma specimens. Results The LASSO Cox regression model identified a nine-gene prognostic signature, including BMP2, NCF1, HSPB1, PIGT, PTX3, CCNA2, CCNB2, CCN4, and DES. Functional enrichment analysis revealed that PTX3-associated differentially expressed genes were significantly enriched in pathways such as cytokine–cytokine receptor interaction and PI3K-Akt signaling, which are critical for immune response and cell proliferation in glioma. PTX3 expression showed a strong correlation with immune cell infiltration, particularly macrophages, neutrophils, T cells, and natural killer cells, suggesting a role in modulating the tumor microenvironment. Pan-cancer analysis indicated that PTX3 is markedly upregulated in various cancers, especially gliomas, highlighting its potential as a biomarker. PTX3 expression was also associated with clinical features such as WHO grade, IDH mutation status, and 1p/19q co-deletion, with higher PTX3 levels linked to poorer survival outcomes. Immunohistochemistry confirmed elevated PTX3 protein expression in both lower-grade glioma and glioblastoma multiforme. Conclusions These findings highlight the critical role of PTX3 in glioma and suggest its potential as both a prognostic biomarker and therapeutic target. This study provides a foundation for future research into targeted therapies involving PTX3.https://peerj.com/articles/19675.pdfPTX3GliomaPoor-prognosis predictorClinical stageImmune cell infiltration
spellingShingle Delin Wang
Cuimei Liu
Bohao Sun
Xiaodong Zhang
Yejun Zhou
Zhonglin Hu
Duanzheng Cao
Jing Zhang
Jinfang Xu
Expression of the IL-18-related gene PTX3 correlates with clinicopathological features and prognosis in glioma patients
PeerJ
PTX3
Glioma
Poor-prognosis predictor
Clinical stage
Immune cell infiltration
title Expression of the IL-18-related gene PTX3 correlates with clinicopathological features and prognosis in glioma patients
title_full Expression of the IL-18-related gene PTX3 correlates with clinicopathological features and prognosis in glioma patients
title_fullStr Expression of the IL-18-related gene PTX3 correlates with clinicopathological features and prognosis in glioma patients
title_full_unstemmed Expression of the IL-18-related gene PTX3 correlates with clinicopathological features and prognosis in glioma patients
title_short Expression of the IL-18-related gene PTX3 correlates with clinicopathological features and prognosis in glioma patients
title_sort expression of the il 18 related gene ptx3 correlates with clinicopathological features and prognosis in glioma patients
topic PTX3
Glioma
Poor-prognosis predictor
Clinical stage
Immune cell infiltration
url https://peerj.com/articles/19675.pdf
work_keys_str_mv AT delinwang expressionoftheil18relatedgeneptx3correlateswithclinicopathologicalfeaturesandprognosisingliomapatients
AT cuimeiliu expressionoftheil18relatedgeneptx3correlateswithclinicopathologicalfeaturesandprognosisingliomapatients
AT bohaosun expressionoftheil18relatedgeneptx3correlateswithclinicopathologicalfeaturesandprognosisingliomapatients
AT xiaodongzhang expressionoftheil18relatedgeneptx3correlateswithclinicopathologicalfeaturesandprognosisingliomapatients
AT yejunzhou expressionoftheil18relatedgeneptx3correlateswithclinicopathologicalfeaturesandprognosisingliomapatients
AT zhonglinhu expressionoftheil18relatedgeneptx3correlateswithclinicopathologicalfeaturesandprognosisingliomapatients
AT duanzhengcao expressionoftheil18relatedgeneptx3correlateswithclinicopathologicalfeaturesandprognosisingliomapatients
AT jingzhang expressionoftheil18relatedgeneptx3correlateswithclinicopathologicalfeaturesandprognosisingliomapatients
AT jinfangxu expressionoftheil18relatedgeneptx3correlateswithclinicopathologicalfeaturesandprognosisingliomapatients